ALMEDIO INC. (7859.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	2.7B	2.4B	5.8B	11.6B	4.9B
Cost of Revenue	507.2M	1.8B	3.7B	6.6B	3.4B
Gross Profit	162.4M	530.6M	2.1B	5.0B	1.6B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	308.0M	1.4B	1.2B	1.6B	1.0B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	308.0M	1.4B	1.2B	1.6B	1.0B
Cost and Expenses	3.1B	3.2B	4.9B	8.2B	4.4B
Operating Income (EBIT)	(402.0M)	(825.0M)	867.0M	3.4B	535.0M
Non-Operating
Interest Income	993.0K	9.1M	5.6M	8.8M	1.6M
Interest Expense	2.0M	6.9M	7.8M	6.0M	5.8M
Net Interest Income	(994.0K)	2.2M	(2.2M)	2.8M	(4.2M)
Other Non-Op Income/Expense	(8.7M)	39.1M	10.0M	78.8M	34.2M
Non-Operating Income (excl Interest)	4.9M	44.0M	20.7M	93.0M	41.9M
EBT (Pre-Tax Income)	(154.1M)	(843.3M)	806.2M	3.3B	417.2M
Income Tax Expense	(38.0M)	(373.0M)	329.8M	949.4M	253.1M
Bottom Line
Net Income	(474.0M)	(470.0M)	476.0M	2.3B	164.0M
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(474.0M)	(470.0M)	476.0M	2.3B	164.0M
Per Share
Basic EPS	(¥24)	(¥23)	¥23	¥123	¥9
Diluted EPS	(¥24)	(¥23)	—	—	¥9
Revenue Per Share	¥137	¥118	¥281	¥613	¥276
Shares
Basic Shares Outstanding	20.0M	20.0M	20.6M	18.9M	17.9M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	(516.5M)	1.1B	3.5B	666.2M
D&A	—	308.5M	236.4M	138.4M	131.2M
EBIT	(402.0M)	(825.0M)	867.0M	3.4B	535.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026